After lot of thought, I've decided on the following:
1. Wait to put stake in Amara Raja, it's quite expensive and run up very fast in last 2 months. Sold off at break even
2. Up my stake in Piramal Enterprises. I'm fairly confident that Mr. Piramal can do better justice than I can...and now I can go and spend time studying more.
3. Freeze further addition to my portfolio. No more fresh purchases. Having said that, yes, I'll sell stocks if they reach my targets, like PNB and INFY, the stalwarts...and rotate the money into other depressed stalwarts. For example, I'm eyeing HEROMOTOCORP, but later on that...
So, here's my new portfolio:
In the next post onwards, I'll focus on new learning and topics I want to focus...the new session of classroom begins :-)
Prudential Investing - A Blog about personal finance, value investing & sustainable economics
Thursday, October 25, 2012
Sunday, October 21, 2012
Exit Plan
Now that I've decided to freeze further purchases in my portfolio for next 6-12 months, I should also be ready with an exit plan given markets run away too fast and I should take some profits to deploy in better opportunities that I'll find in this study period.
Essentially, over last few weeks, I've found that my portfolio contains some decent stocks, but I can find better stories. The following are the reasons:
1. My portfolio primarily contains quantitatively undervalued stocks, not necessarily qualitatively great stocks at right price. I'm shifting towards finding businesses with strong moat and buying them undervalued when all hell is loose...times that come rarely, like in Dec 2011, June 2012 (for a subset of businesses), Oct-2009 to Mar 2010 and alike.
2. I risk holding some value traps, like SRF, MAZDA, not because they're bad businesses, but market may never re-rate their valuations. Hence, I'll freeze any further addition to these positions, and rather exit them for some profit (I've a strong conviction that markets will move towards all time high in next one year, more chances of this happening than a crash back to sub 5000 levels)
3. I'm already finding better opportunities, though they're expensive now, like Amara Raja Batteries, Shriram Transport Finance, etc, and will need funds for these when markets revert back again later, after hitting a peak.
Ok, so here's the exit plan - in order in which I'll sell them
- offload another 20-30% when it reaches towards Rs 300
Other than these, I might exit some stake in other stocks, in general if they run up too fast, but only if I have great confidence to be able to re-allocate them to better opportunities.
Ok, final word - no more purchases until study progresses a good deal, exceptions being
- PEL falls below Rs 450
- Amara Raja falls below Rs 200
- IGL falls below Rs 210
- MAZDA falls below Rs 82
Otherwise, I'm happy to stick to 90% invested status and focus on studies... :-)
Essentially, over last few weeks, I've found that my portfolio contains some decent stocks, but I can find better stories. The following are the reasons:
1. My portfolio primarily contains quantitatively undervalued stocks, not necessarily qualitatively great stocks at right price. I'm shifting towards finding businesses with strong moat and buying them undervalued when all hell is loose...times that come rarely, like in Dec 2011, June 2012 (for a subset of businesses), Oct-2009 to Mar 2010 and alike.
2. I risk holding some value traps, like SRF, MAZDA, not because they're bad businesses, but market may never re-rate their valuations. Hence, I'll freeze any further addition to these positions, and rather exit them for some profit (I've a strong conviction that markets will move towards all time high in next one year, more chances of this happening than a crash back to sub 5000 levels)
3. I'm already finding better opportunities, though they're expensive now, like Amara Raja Batteries, Shriram Transport Finance, etc, and will need funds for these when markets revert back again later, after hitting a peak.
Ok, so here's the exit plan - in order in which I'll sell them
SRF - Based on the concerns of this being a value trap, I plan to
- sell 30% of my holding when SRF crosses Rs 240 or so. Looking at the trend, I may sell just before dividend, since it always falls post dividend payments (ex-date)- offload another 20-30% when it reaches towards Rs 300
PNB
As mentioned, if it goes above 950 - 1000, I'll exit this stock. Good bank, but risk of asset quality is not justified at Rs 1000, at least until FY14.INFY
Again, its a stalwart dumped by market, and I'll exit (at least 30%) this when it again starts trading above a P/E of 20.Other than these, I might exit some stake in other stocks, in general if they run up too fast, but only if I have great confidence to be able to re-allocate them to better opportunities.
Ok, final word - no more purchases until study progresses a good deal, exceptions being
- PEL falls below Rs 450
- Amara Raja falls below Rs 200
- IGL falls below Rs 210
- MAZDA falls below Rs 82
Otherwise, I'm happy to stick to 90% invested status and focus on studies... :-)
What all can go wrong with SRF
While I posted all good about SRF recently, considering some new learning in recent past, and the fact that I'm finding new, supposedly better opportunities, and the fact that SRF represents 11%+ of my portfolio currently (and when I get 100% invested, it'll still be 10% of my portfolio), a reality check is needed.
Let's see what all can go wrong with this business and the stock.
Business Moat
1. Strong Brand: SRF is a leader in its industry - man-made fibres. However, since this industry has a small barrier to entry, there's no strong brand, but yes, SRF does enjoy a leadership position.
2. Distribution network: Searching for 'SRF distributors' does bring up many links on Google, and considering they're growing sales at a decent pace of 20%+ in last 3-5 years, SRF does have a moderately strong distribution network.
3. Intellectual Property: Yes, SRF has a strong team of chemical scientists and does have some strength of IP rights. As mentioned, all business verticals are engaged in development of newer molecules, and this will help SRF bring newer products with better quality that competition can't bring, and hence some moat here as well.
4. Lowest Cost: Not really, but yes, operating margins are improving.
5. Barrier to switching: Somewhat. Since the consumers are into industrial businesses, it is not safe to change the suppliers without risk of quality issues, and hence SRF does enjoy a protection against losing existing customers, provided they maintain quality and competetive pricing.
Ok, so business moat is decent to moderately good, and given cheap valuations, risk of a significant downgrade in Intrinsic value of the business is limited, if not zero.
One risk is that of increasing debt, due to expansion and which could eat into profits and hence dividend yield. Let's consider a bear case. If profits were to decline by 40%, with current dividend payout rate of 20% of profits, there's a good deal of risk to lower dividends, given the outflows in increasing interest and debt payments.
Second is that due to an economic slowdown. If industrial output falls further, there'll be a hit on topline growth, or even a decline in topline for SRF.
Market re-rating is another risk. Historically, the P/E ratio for SRF has on an average been around 3-5 range, and hence scope for a large increase in P/E is unlikely.
However, the good part is that SRF stock has seen a steep fall in prices due to recent quarter poor performance. Current P/E of 3.88 is against an annual PAT of Rs 326 cr. However, assuming best case, the profit can jump back to 400+ levels, and then at a P/E of 4, the stock price can come back to 300 or so levels.
Having said that, it is unlikely that SRF will ever trade above the Intrinsic Value, which is significantly higher at Rs 450+.
All in all, it makes sense to hold this to milk the nice 3.5% half-yearly dividend due in November and then the rest 3.5% in March (this is the annual track record of dividend payment by SRF), and sell it when it starts tading at PE 4.5 or higher, simple reason being that chances of this stock generating low returns is larger than anything. It may not crash further, but it is a kind of stock which trades mostly undervalued, at a discount to the IV, and hence, the only gain possible is through dividends & increase in IV, with market price discount remaining constant.
So, the final action is to wait and watch - no reduction in stake given dividend income and improving market sentiments, and the very attractive purchase price of Rs. 207, but the change is that I won't hold it for very long term...
Let's see what all can go wrong with this business and the stock.
Business Moat
1. Strong Brand: SRF is a leader in its industry - man-made fibres. However, since this industry has a small barrier to entry, there's no strong brand, but yes, SRF does enjoy a leadership position.
2. Distribution network: Searching for 'SRF distributors' does bring up many links on Google, and considering they're growing sales at a decent pace of 20%+ in last 3-5 years, SRF does have a moderately strong distribution network.
3. Intellectual Property: Yes, SRF has a strong team of chemical scientists and does have some strength of IP rights. As mentioned, all business verticals are engaged in development of newer molecules, and this will help SRF bring newer products with better quality that competition can't bring, and hence some moat here as well.
4. Lowest Cost: Not really, but yes, operating margins are improving.
5. Barrier to switching: Somewhat. Since the consumers are into industrial businesses, it is not safe to change the suppliers without risk of quality issues, and hence SRF does enjoy a protection against losing existing customers, provided they maintain quality and competetive pricing.
Ok, so business moat is decent to moderately good, and given cheap valuations, risk of a significant downgrade in Intrinsic value of the business is limited, if not zero.
One risk is that of increasing debt, due to expansion and which could eat into profits and hence dividend yield. Let's consider a bear case. If profits were to decline by 40%, with current dividend payout rate of 20% of profits, there's a good deal of risk to lower dividends, given the outflows in increasing interest and debt payments.
Second is that due to an economic slowdown. If industrial output falls further, there'll be a hit on topline growth, or even a decline in topline for SRF.
Market re-rating is another risk. Historically, the P/E ratio for SRF has on an average been around 3-5 range, and hence scope for a large increase in P/E is unlikely.
However, the good part is that SRF stock has seen a steep fall in prices due to recent quarter poor performance. Current P/E of 3.88 is against an annual PAT of Rs 326 cr. However, assuming best case, the profit can jump back to 400+ levels, and then at a P/E of 4, the stock price can come back to 300 or so levels.
Having said that, it is unlikely that SRF will ever trade above the Intrinsic Value, which is significantly higher at Rs 450+.
All in all, it makes sense to hold this to milk the nice 3.5% half-yearly dividend due in November and then the rest 3.5% in March (this is the annual track record of dividend payment by SRF), and sell it when it starts tading at PE 4.5 or higher, simple reason being that chances of this stock generating low returns is larger than anything. It may not crash further, but it is a kind of stock which trades mostly undervalued, at a discount to the IV, and hence, the only gain possible is through dividends & increase in IV, with market price discount remaining constant.
So, the final action is to wait and watch - no reduction in stake given dividend income and improving market sentiments, and the very attractive purchase price of Rs. 207, but the change is that I won't hold it for very long term...
Amara Raja Batteries
This is an exciting story which I've come across, both on forums, and found it in my stock screens too.
Here's a nice analysis of this business. I'm fairly confident that this business has a growing moat that can keep the profits growing for next 5-10 years.
Here I perform my own analysis of fair value:
1. The business has a 3y average EBIT of Rs 15.5 / share. Based on debt capacity bargain criteria of 1.75X debt capacity, or EV/EBIDTA of 7 or lesser, certainly the stock is expensive. This way, the fair value using 3y average is Rs 108, and using current EBIT (since the company is growing fast), it is Rs 152.
Note that I've ignored cash and investment and dividend to offset debt on the books.
2. The PEG for the company is certainly less than 1. In fact, at P/E of 16, it is still trading less than 20%+ growth rate in profits, and a significant re-rating is possible given the valuation multiples of Exide are much higher.
3. The current price of Rs 230 / share is all right - its fairly valued, and given strengths of business, and growing moat, it can sustain revised valuations of about 15X P/E or even higher.
However, the following are the risks:
1. If EXIDE falters and its downward rating happens, Amara Raja may not be able to sustain higher valuations and can come down (I really wish that happens)
2. If economy weakens further, demand may dampen and this poses risk to topline growth.
3. The management addresses the risks in AR, but seems a little too optimistic about being able to handle them. Specifically, they say the following:
a. They've reached a large base and it is difficult to continue growing fast
b. Even then, they want to double their topline in next 3-4 years!
Certainly, this is a little too optimistic, and will have to be funded through debt. So, there's a risk to reduced EBIT and hence PEG may go more than 1 very soon. This could pose risk to downside in stock price if macro economics remains bad for months and years to come.
In essence, I see a risk that stock price has run up quite fast, and chances are that price may not go much higher, if bad things happen. Hence, best case scenario is that it'll continue to grow and rerating continues and stock can easily move up to 300+ very soon from today's level of 240
But the bear case tells us that stock is fully pricing all positives at current price, and there's little to zero margin of safety right now.
Hence, I'll not take major position until it comes down to Rs 200 or below. In fact, I'll only take large positions if it drops below Rs 175
However, to make sure I don't miss out best case scenario and then repent for not having bought a spectacular business, I'll do the following:
1. Keep accumulating on dips up to a maximum of 4% of my portfolio.
2. When it crashes below Rs 175, slowly catch it to accumulate up to 10% of my portfolio.
Patience is going to be the key here. However, certainly it looks a great business, at fair price, and hence I'll start putting my bets, slowly and carefully, and wish markets start falling :-)
Here's a nice analysis of this business. I'm fairly confident that this business has a growing moat that can keep the profits growing for next 5-10 years.
Here I perform my own analysis of fair value:
1. The business has a 3y average EBIT of Rs 15.5 / share. Based on debt capacity bargain criteria of 1.75X debt capacity, or EV/EBIDTA of 7 or lesser, certainly the stock is expensive. This way, the fair value using 3y average is Rs 108, and using current EBIT (since the company is growing fast), it is Rs 152.
Note that I've ignored cash and investment and dividend to offset debt on the books.
2. The PEG for the company is certainly less than 1. In fact, at P/E of 16, it is still trading less than 20%+ growth rate in profits, and a significant re-rating is possible given the valuation multiples of Exide are much higher.
3. The current price of Rs 230 / share is all right - its fairly valued, and given strengths of business, and growing moat, it can sustain revised valuations of about 15X P/E or even higher.
However, the following are the risks:
1. If EXIDE falters and its downward rating happens, Amara Raja may not be able to sustain higher valuations and can come down (I really wish that happens)
2. If economy weakens further, demand may dampen and this poses risk to topline growth.
3. The management addresses the risks in AR, but seems a little too optimistic about being able to handle them. Specifically, they say the following:
a. They've reached a large base and it is difficult to continue growing fast
b. Even then, they want to double their topline in next 3-4 years!
Certainly, this is a little too optimistic, and will have to be funded through debt. So, there's a risk to reduced EBIT and hence PEG may go more than 1 very soon. This could pose risk to downside in stock price if macro economics remains bad for months and years to come.
In essence, I see a risk that stock price has run up quite fast, and chances are that price may not go much higher, if bad things happen. Hence, best case scenario is that it'll continue to grow and rerating continues and stock can easily move up to 300+ very soon from today's level of 240
But the bear case tells us that stock is fully pricing all positives at current price, and there's little to zero margin of safety right now.
Hence, I'll not take major position until it comes down to Rs 200 or below. In fact, I'll only take large positions if it drops below Rs 175
However, to make sure I don't miss out best case scenario and then repent for not having bought a spectacular business, I'll do the following:
1. Keep accumulating on dips up to a maximum of 4% of my portfolio.
2. When it crashes below Rs 175, slowly catch it to accumulate up to 10% of my portfolio.
Patience is going to be the key here. However, certainly it looks a great business, at fair price, and hence I'll start putting my bets, slowly and carefully, and wish markets start falling :-)
Saturday, October 20, 2012
Portfolio status and expectation
In the last few days, I've made many incremental purchases, and I'm getting closer to going 100% invested in my target portfolio (~45% of net-worth in equity). If I ignore illiquid investments, this composes about 70% equity and 30% debt + cash.
Ok, I've increased stake in Piramal Enterprises, Mazda and IGL, while completing full investment in many others. Here's the composition.
Note that I've taken a small tracking position in Amara Raja Batteries. At this point, I'm about to freeze my portfolio for next 6-12 months, with the following decisions:
1. No increase in number of stocks any further.
2. No increase in investments in top 7 stocks (BHEL, SRF, BHARTIARTL, CROMPGREAV, INFY, MOIL, OPTOCIRCUITS)
3. Need to analyze SRF again, and see if it would be prudent to reduce it, purely due to the concern of a little higher debt level, slower growth outlook and risk that it is a small company, relatively. Needs more analysis.
4. PEL is about 6.7% of my portfolio, but before I take it to full 10% level, need to stock and do some some critical analysis...primarily on the fact that can I buy it lower in next few months, and the fact that whether there're some serious concerns about the pharma business and infusion into real estate and financial divisions.
5. No further increase in IGL, as I wrote in the post. It is good business, but to balance the risk of pricing regulations, I decide to limit the exposure.
6. Choose if it makes sense to further increase stake in MAZDA, or if Amara Raja Batteries turns out to be a better bet.
In all, I've about 10% surplus funds, and need to choose which makes the best investment out of PEL, MAZDA and AMARA RAJA batteries. As far as PNB is concerned, I won't liquidate it - it can give decent returns + dividends when market bull phase comes back in full swing.
I performed an expectation analysis also, here's the summary:
As you can see, I've listed my average purchase price, my calculated Intrinsic Value / fair price and the 3 year average dividend payout, and accordingly, my portfolio dividend yield is a decent, if not great, 2.64%. Also, assuming markets will revert to mean in next 3 years, my portfolio can earn about 102% profits, which amount to a handsome 26% CAGR!!! Not to account for 2.64% annual dividends, yielding to a total expected return or about 30% from this portfolio.
While this might be a little overstretched, but then, we know a very bullish market can become highly irrational, and that's the time to take some profits and channelize into better opportunities.
I'll now soon freeze my portfolio (except selling if something flies away too fast, potential candidates being PNB, INFY and smaller stocks...) and focus back on continuing reading. Need to structure the reading, so much to read, but need to prioritize...just need to spend couple more weeks on completing this choice of 10% incremental investment in MAZDA, PEL or AMARA RAJA, and think if need to reduce stake in SRF
Let's see how things unfold...
Ok, I've increased stake in Piramal Enterprises, Mazda and IGL, while completing full investment in many others. Here's the composition.
Note that I've taken a small tracking position in Amara Raja Batteries. At this point, I'm about to freeze my portfolio for next 6-12 months, with the following decisions:
1. No increase in number of stocks any further.
2. No increase in investments in top 7 stocks (BHEL, SRF, BHARTIARTL, CROMPGREAV, INFY, MOIL, OPTOCIRCUITS)
3. Need to analyze SRF again, and see if it would be prudent to reduce it, purely due to the concern of a little higher debt level, slower growth outlook and risk that it is a small company, relatively. Needs more analysis.
4. PEL is about 6.7% of my portfolio, but before I take it to full 10% level, need to stock and do some some critical analysis...primarily on the fact that can I buy it lower in next few months, and the fact that whether there're some serious concerns about the pharma business and infusion into real estate and financial divisions.
5. No further increase in IGL, as I wrote in the post. It is good business, but to balance the risk of pricing regulations, I decide to limit the exposure.
6. Choose if it makes sense to further increase stake in MAZDA, or if Amara Raja Batteries turns out to be a better bet.
In all, I've about 10% surplus funds, and need to choose which makes the best investment out of PEL, MAZDA and AMARA RAJA batteries. As far as PNB is concerned, I won't liquidate it - it can give decent returns + dividends when market bull phase comes back in full swing.
I performed an expectation analysis also, here's the summary:
Stock Holding | Purchase Price / CMP | Fair Value Estimate | 1.5X fair value reversion | Potential upside due to 1.5X fair value reversion | 3y average dividend yield |
BHEL | Rs. 220.50 | Rs. 322.00 | Rs. 483.00 | 119.05% | 2.61% |
BHARTIARTL | Rs. 263.90 | Rs. 300.00 | Rs. 450.00 | 70.52% | 0.38% |
SRF | Rs. 206.73 | Rs. 480.00 | Rs. 720.00 | 248.28% | 6.77% |
CROMPGREAV | Rs. 129.28 | Rs. 100.00 | Rs. 150.00 | 16.03% | 1.49% |
MOIL | Rs. 251.11 | Rs. 314.00 | Rs. 471.00 | 87.57% | 2.26% |
Opto circuits | Rs. 128.96 | Rs. 180.00 | Rs. 270.00 | 109.37% | 2.97% |
INFY | Rs. 2,249.88 | Rs. 2,318.00 | Rs. 3,477.00 | 54.54% | 1.96% |
PEL | Rs. 472.86 | Rs. 680.00 | Rs. 1,020.00 | 115.71% | 2.46% |
PNB | Rs. 709.07 | Rs. 1,143.00 | Rs. 1,714.50 | 141.80% | 3.10% |
IGL | Rs. 261.49 | Rs. 221.00 | Rs. 331.50 | 26.77% | 1.85% |
MAZDA | Rs. 98.63 | Rs. 134.00 | Rs. 201.00 | 103.79% | 3.55% |
AMARA RAJA BATTERIES | Rs. 227.13 | Rs. 150.00 | Rs. 225.00 | -0.94% | 1.66% |
102.15% | 2.64% |
As you can see, I've listed my average purchase price, my calculated Intrinsic Value / fair price and the 3 year average dividend payout, and accordingly, my portfolio dividend yield is a decent, if not great, 2.64%. Also, assuming markets will revert to mean in next 3 years, my portfolio can earn about 102% profits, which amount to a handsome 26% CAGR!!! Not to account for 2.64% annual dividends, yielding to a total expected return or about 30% from this portfolio.
While this might be a little overstretched, but then, we know a very bullish market can become highly irrational, and that's the time to take some profits and channelize into better opportunities.
I'll now soon freeze my portfolio (except selling if something flies away too fast, potential candidates being PNB, INFY and smaller stocks...) and focus back on continuing reading. Need to structure the reading, so much to read, but need to prioritize...just need to spend couple more weeks on completing this choice of 10% incremental investment in MAZDA, PEL or AMARA RAJA, and think if need to reduce stake in SRF
Let's see how things unfold...
Will come back again, IL&FS
I found this interesting business in my stock screen, but looking at annual report, I'm not very confident if I can analyze it today, so just keeping it in my watchlist and will come back soon...
I really like Amara Raja Batteries, and have taken a small tracking position also, and this will be the stock I'll analyze before freezing...and accordingly re-adjust capital based on my conviction.
I've kept two more stocks in my watchlist (SWARAJ ENGINES & ECLERX SERVICES), but will not analyze them right now as I'm deciding to freeze my portfolio for next 6-12 months. Will spend time on studying books and reading good articles on value investing...
I really like Amara Raja Batteries, and have taken a small tracking position also, and this will be the stock I'll analyze before freezing...and accordingly re-adjust capital based on my conviction.
I've kept two more stocks in my watchlist (SWARAJ ENGINES & ECLERX SERVICES), but will not analyze them right now as I'm deciding to freeze my portfolio for next 6-12 months. Will spend time on studying books and reading good articles on value investing...
Thursday, October 18, 2012
A re-look at IGL
Since last one week, I've been analyzing new opportunities (MAZDA, PEL) and find that maybe, they're safer bets compared to IGL. No doubt IGL is a good business, but given the risk / reward ratio, I'd be more comfortable to put my bet on MAZDA due to a simple business with decent moat, able management, small enough to keep growing and a good deal of undervalued stock, and PEL due to skills of Mr. Piramal and the fact that this company has a lot of cash to look out for good opportunities, and I'm getting an entry into drug discovery + pharma + healthcare analytics as a debt capacity bargain.
Hence, I bought some more yesterday at rs 256 and finalize the infusion in IGL. I'll stop for now, and only think again about IGL if
1. It drops below Rs 200 with no further degradation in fundamentals
2. I have surplus cash and no other better opportunity (after exhausting the limit of 7% on MAZDA and 10% on PEL)
I still have some position and can benefit the rise in IGL due to PNG growth in NCR, which is my primary reason to like the stock. And due to small concerntration in portfolio, the risk of further pricing regulation is contained.
Next post, to resolve confusion on SRF and take a call for reducing or maintaining the position...
Hence, I bought some more yesterday at rs 256 and finalize the infusion in IGL. I'll stop for now, and only think again about IGL if
1. It drops below Rs 200 with no further degradation in fundamentals
2. I have surplus cash and no other better opportunity (after exhausting the limit of 7% on MAZDA and 10% on PEL)
I still have some position and can benefit the rise in IGL due to PNG growth in NCR, which is my primary reason to like the stock. And due to small concerntration in portfolio, the risk of further pricing regulation is contained.
Next post, to resolve confusion on SRF and take a call for reducing or maintaining the position...
Subscribe to:
Posts (Atom)